Novo Nordisk A/S $45.1412 (-0.65, 1.44%)

US
95% success, from Analysis 1* of this Model (*Public)
Summary
SHORTSELL: Best moves 17 which gains 728.44, return on capital invested 10.11%
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date UTC Location Action Description Object Severity User Action